CME proposes sale of 4,200 common shares
CME Group submitted a Form 144 reporting a proposed sale of common shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
CME Group submitted a Form 144 reporting a proposed sale of common shares. The notice lists a broker, Morgan Stanley Smith Barney LLC, and an intended sale date of 02/23/2026. The filing itemizes equity awards: 218 performance stock units (03/15/2021), 3,285 performance stock units (03/15/2021) and 697 restricted shares (09/15/2019).
Insights
Form 144 documents a brokered proposed sale of listed common shares by an insider.
Form 144s serve as a notice of proposed sales under resale rules; this filing names Morgan Stanley Smith Barney LLC as the broker and cites an intended sale date of 02/23/2026. The itemized amounts—218, 3,285, and 697—are listed as award types with their original grant dates.
Execution, settlement, and exact proceeds depend on subsequent broker activity and sale confirmations; timing and cash‑flow treatment are not specified in the provided excerpt. Subsequent filings or broker reports would show completed sale details.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does CME's Form 144 report?
How many equity awards are listed on the filing for CME?
Does the Form 144 state how much cash CME will receive?
Who is the broker handling the proposed sale in CME's Form 144?
AI-generated analysis. How Rhea-AI works. Not financial advice.